Antagonism of Opioid-Induced Respiratory Depression by CX1739 With Preservation of Opioid Analgesia

Clinical trial NCT02735629 · UNKNOWN

Trial details

NCT number: NCT02735629
Sponsor: RespireRx
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Opiate Induced Respiratory Depression

Start date: 2016-03-01
Primary completion: 2016-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.